$APHP
American Picture House Corp Stock $aphp

$aphp Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019186 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue		$23.00K	$169.1K
YoY Change		-86.4%
Cost Of Revenue			$36.70K
YoY Change
Gross Profit		$23.00K	$132.4K
YoY Change		-82.63%
Gross Profit Margin		100.0%	78.3%
Selling, General & Admin	$391.4K	$1.516M
YoY Change	-0.93%
% of Gross Profit		6590.04%
Research & Development	$703.00
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.830K	$750.00
YoY Change
% of Gross Profit		3.26%
Operating Expenses	$392.1K	$1.516M	$183.6K
YoY Change	-0.76%	725.64%
Operating Profit	-$392.1K	-$1.493M	-$51.19K
YoY Change	-0.76%	2816.23%
Interest Expense	-$12.44K	$3.185K	$1.888K
YoY Change	3558.82%	68.7%
% of Operating Profit
Other Income/Expense, Net	-$12.44K	-$3.083K	-$1.147K
YoY Change	3536.26%	168.79%
Pretax Income	-$404.6K	-$1.496M	-$52.34K
YoY Change	2.3%	2758.21%
Income Tax
% Of Pretax Income
Net Earnings	-$404.6K	-$1.496M	-$52.34K
YoY Change	2.3%	2758.26%	-24.4%
Net Earnings / Revenue		-6503.44%	-30.95%
Basic Earnings Per Share	$0.00	-$0.01	$0.00
Diluted Earnings Per Share	$0.00	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	111.4M shares	109.9M shares	100.7M shares
Diluted Shares Outstanding	111.3M shares	109.9M shares	100.7M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.060K	$25.13K
YoY Change	-96.97%
Cash & Equivalents	$8.058K	$25.13K	$16.64K
Short-Term Investments
Other Short-Term Assets	$9.600K	$13.37K
YoY Change	-73.49%
Inventory
Prepaid Expenses	$9.601K	$13.37K
Receivables	$38.71K	$51.78K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$56.37K	$90.89K
YoY Change	-82.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$87.28K	$74.11K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$346.6K	$200.4K
YoY Change	163.44%
Total Long-Term Assets	$830.0K	$494.5K
YoY Change	530.97%
TOTAL ASSETS
Total Short-Term Assets	$56.37K	$90.89K
Total Long-Term Assets	$830.0K	$494.5K
Total Assets	$886.4K	$585.4K
YoY Change	92.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$502.6K	$48.71K
YoY Change	319.56%
Accrued Expenses	$17.44K	$12.53K
YoY Change	26.01%
Deferred Revenue
YoY Change
Short-Term Debt	$113.5K	$250.0K
YoY Change	10.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$683.5K	$361.2K
YoY Change	189.44%
LONG-TERM LIABILITIES
Long-Term Debt	$149.9K	$149.9K
YoY Change	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$149.9K	$149.9K
YoY Change	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$683.5K	$361.2K
Total Long-Term Liabilities	$149.9K	$149.9K
Total Liabilities	$833.4K	$511.1K
YoY Change	115.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.922M	-$6.518M
YoY Change
Common Stock	$11.14K	$471.6K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.03K	$74.27K	-$15.10K
YoY Change
Total Liabilities & Shareholders Equity	$886.4K	$585.4K
YoY Change	92.56%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$404.6K	-$1.496M	-$52.34K
YoY Change	2.3%	2758.26%	-24.4%
Depreciation, Depletion And Amortization	$5.830K	$750.00
YoY Change
Cash From Operating Activities	-$305.8K	-$436.1K	-$129.9K
YoY Change	-3.85%	235.65%
INVESTING ACTIVITIES
Capital Expenditures	$19.00K	$3.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$2.820K	-$4.770K
YoY Change	-72.35%
Cash From Investing Activities	-$21.82K	-$7.770K	-$10.02K
YoY Change	113.92%	-22.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	310.6K	$265.0K	$125.0K
YoY Change	-44.77%	112.0%
NET CHANGE
Cash From Operating Activities	-305.8K	-$436.1K	-$129.9K
Cash From Investing Activities	-21.82K	-$7.770K	-$10.02K
Cash From Financing Activities	310.6K	$265.0K	$125.0K
Net Change In Cash	-17.06K	-$178.8K	-$14.93K
YoY Change	-107.29%	1097.57%
FREE CASH FLOW
Cash From Operating Activities	-$305.8K	-$436.1K	-$129.9K
Capital Expenditures	$19.00K	$3.000K
Free Cash Flow	-$324.8K	-$439.1K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51775	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13367	usd
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-4154740
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	477 Madison Avenue, 6th Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2024Q1	dei	City Area Code CityAreaCode	1-800
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	689-6885
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	36701	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	183603	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100735159	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	100735159	shares
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31573	usd
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001771995
CY2023Q4	APHP	Loans Receivable Film Financing Arrangements LoansReceivableFilmFinancingArrangements		usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent		usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	APHP	Expiration Of Produced And Licensed Costs ExpirationOfProducedAndLicensedCosts		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		usd
CY2023Q1	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent		usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	APHP	Conversion Of Accrued Expenses Into Options To Purchase Common Stock ConversionOfAccruedExpensesIntoOptionsToPurchaseCommonStock		usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P3Y
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-56586
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	American Picture House Corporation
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	111399325	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25126	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	90889	usd
CY2024Q1	APHP	Produced And Licensed Content Costs ProducedAndLicensedContentCosts	200403	usd
CY2024Q1	APHP	Loans Receivable Film Financing Arrangements LoansReceivableFilmFinancingArrangements	220000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1750	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	74114	usd
CY2024Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	366387	usd
CY2023Q4	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	366387	usd
CY2024Q1	us-gaap	Assets Assets	585406	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	48710	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	50000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	361240	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	101957	usd
CY2024Q1	APHP	Economic Injury Disaster Loan Noncurrent EconomicInjuryDisasterLoanNoncurrent	149900	usd
CY2023Q4	APHP	Economic Injury Disaster Loan Noncurrent EconomicInjuryDisasterLoanNoncurrent	149900	usd
CY2024Q1	us-gaap	Liabilities Liabilities	511140	usd
CY2023Q4	us-gaap	Liabilities Liabilities	251857	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109865991	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109865991	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109790991	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109790991	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	471577	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	471569	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3829	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3829	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3829	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3829	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6120372	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4847220	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6517683	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5021696	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	74266	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297093	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	585406	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	548950	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23003	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169111	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	23003	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	132410	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1501932	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13975	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1515907	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	183603	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1492904	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-51193	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	102	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	741	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	3185	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1888	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3083	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1147	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1495987	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52340	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1495987	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52340	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109865001	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109865001	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-67756	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	105000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1160221	shares
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	105000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52340	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-15096	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297093	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297093	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1258160	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1495987	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	74266	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	74266	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1495987	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52340	usd
CY2024Q1	APHP	Expiration Of Produced And Licensed Costs ExpirationOfProducedAndLicensedCosts	15000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1258160	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	750	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19827	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-109702	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-15818	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-17838	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-168	usd
CY2024Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-728	usd
CY2024Q1	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	220000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-41667	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-41783	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-130000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	50000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-35000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-436075	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-129918	usd
CY2024Q1	APHP	Payments To Produced And Licensed Costs PaymentsToProducedAndLicensedCosts	4770	usd
CY2023Q1	APHP	Payments To Produced And Licensed Costs PaymentsToProducedAndLicensedCosts	10016	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7770	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10016	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	125000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	265000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	125000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-178845	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14934	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	203971	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25126	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16639	usd
CY2023Q1	APHP	Conversion Of Accrued Expenses Into Options To Purchase Common Stock ConversionOfAccruedExpensesIntoOptionsToPurchaseCommonStock	105000	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	APHP	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
CY2024Q1	APHP	Working Capital WorkingCapital	-270351	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6517683	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zTGFGsVPiUA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zD3uIQlB9DTd">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amount of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51775	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31948	usd
CY2023Q4	us-gaap	Allowance For Uncollectible Customers Liability For Acceptances AllowanceForUncollectibleCustomersLiabilityForAcceptances	193932	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13367	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	29185	usd
CY2024Q1	APHP	Filims In Development And Preproduction Stage FilimsInDevelopmentAndPreproductionStage	200403	usd
CY2023Q4	APHP	Filims In Development And Preproduction Stage FilimsInDevelopmentAndPreproductionStage	210633	usd
CY2024Q1	APHP	Produced And Licensed Content Costs ProducedAndLicensedContentCosts	200403	usd
CY2023Q4	APHP	Produced And Licensed Content Costs ProducedAndLicensedContentCosts	210633	usd
CY2024Q1	APHP	Impairment Assessment For Investment In Films And Licensed Program Rights Write Off ImpairmentAssessmentForInvestmentInFilmsAndLicensedProgramRightsWriteOff	15000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	750	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	50000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	50000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	387983471	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	382900000	shares
CY2024Q1	APHP	Working Capital WorkingCapital	-270351	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6517683	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	178500	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	178500	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.044	pure
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	75864	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72684	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1750	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	74114	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	71684	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	750	usd
CY2021Q1	APHP	Economic Injury Disaster Loan Noncurrent EconomicInjuryDisasterLoanNoncurrent	149900	usd
CY2021Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P30Y
CY2021Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0375	pure
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	100000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5083471	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0125
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	1	pure
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1258160	usd
CY2024Q1	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	0	usd
CY2023Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	20000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	105000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1160221	shares
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.125

Files In Submission

Name	View Source	Status
0001493152-24-019186-index-headers.html	Edgar Link	pending
0001493152-24-019186-index.html	Edgar Link	pending
0001493152-24-019186.txt	Edgar Link	pending
0001493152-24-019186-xbrl.zip	Edgar Link	pending
aphp-20240331.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-10.htm	Edgar Link	pending
ex10-101_001.jpg	Edgar Link	pending
ex10-10_001.jpg	Edgar Link	pending
ex10-10_002.jpg	Edgar Link	pending
ex10-10_003.jpg	Edgar Link	pending
ex10-10_004.jpg	Edgar Link	pending
ex10-10_005.jpg	Edgar Link	pending
ex10-10_006.jpg	Edgar Link	pending
ex10-10_007.jpg	Edgar Link	pending
ex10-10_008.jpg	Edgar Link	pending
ex10-10_1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-1_006.jpg	Edgar Link	pending
ex10-1_1.htm	Edgar Link	pending
ex10-1_1001.jpg	Edgar Link	pending
ex10-1_1002.jpg	Edgar Link	pending
ex10-1_1003.jpg	Edgar Link	pending
ex10-1_1004.jpg	Edgar Link	pending
ex10-1_1005.jpg	Edgar Link	pending
ex10-1_1006.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-2_002.jpg	Edgar Link	pending
ex10-2_003.jpg	Edgar Link	pending
ex10-2_004.jpg	Edgar Link	pending
ex10-2_005.jpg	Edgar Link	pending
ex10-2_006.jpg	Edgar Link	pending
ex10-2_007.jpg	Edgar Link	pending
ex10-2_008.jpg	Edgar Link	pending
ex10-2_009.jpg	Edgar Link	pending
ex10-2_010.jpg	Edgar Link	pending
ex10-2_011.jpg	Edgar Link	pending
ex10-2_012.jpg	Edgar Link	pending
ex10-2_013.jpg	Edgar Link	pending
ex10-2_014.jpg	Edgar Link	pending
ex10-2_015.jpg	Edgar Link	pending
ex10-2_016.jpg	Edgar Link	pending
ex10-2_017.jpg	Edgar Link	pending
ex10-2_018.jpg	Edgar Link	pending
ex10-2_019.jpg	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-3_001.jpg	Edgar Link	pending
ex10-3_002.jpg	Edgar Link	pending
ex10-3_003.jpg	Edgar Link	pending
ex10-3_004.jpg	Edgar Link	pending
ex10-3_005.jpg	Edgar Link	pending
ex10-3_006.jpg	Edgar Link	pending
ex10-3_007.jpg	Edgar Link	pending
ex10-3_008.jpg	Edgar Link	pending
ex10-3_009.jpg	Edgar Link	pending
ex10-3_010.jpg	Edgar Link	pending
ex10-3_011.jpg	Edgar Link	pending
ex10-3_012.jpg	Edgar Link	pending
ex10-3_013.jpg	Edgar Link	pending
ex10-3_014.jpg	Edgar Link	pending
ex10-3_015.jpg	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex10-4_002.jpg	Edgar Link	pending
ex10-4_003.jpg	Edgar Link	pending
ex10-4_004.jpg	Edgar Link	pending
ex10-4_005.jpg	Edgar Link	pending
ex10-4_006.jpg	Edgar Link	pending
ex10-4_007.jpg	Edgar Link	pending
ex10-4_008.jpg	Edgar Link	pending
ex10-4_009.jpg	Edgar Link	pending
ex10-4_010.jpg	Edgar Link	pending
ex10-4_011.jpg	Edgar Link	pending
ex10-4_012.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-5_001.jpg	Edgar Link	pending
ex10-5_002.jpg	Edgar Link	pending
ex10-5_003.jpg	Edgar Link	pending
ex10-5_004.jpg	Edgar Link	pending
ex10-5_005.jpg	Edgar Link	pending
ex10-5_006.jpg	Edgar Link	pending
ex10-5_007.jpg	Edgar Link	pending
ex10-5_008.jpg	Edgar Link	pending
ex10-5_009.jpg	Edgar Link	pending
ex10-5_010.jpg	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.jpg	Edgar Link	pending
ex10-6_002.jpg	Edgar Link	pending
ex10-6_1.htm	Edgar Link	pending
ex10-6_1001.jpg	Edgar Link	pending
ex10-6_1002.jpg	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex10-7_001.jpg	Edgar Link	pending
ex10-7_002.jpg	Edgar Link	pending
ex10-7_003.jpg	Edgar Link	pending
ex10-7_004.jpg	Edgar Link	pending
ex10-7_005.jpg	Edgar Link	pending
ex10-7_006.jpg	Edgar Link	pending
ex10-7_007.jpg	Edgar Link	pending
ex10-7_008.jpg	Edgar Link	pending
ex10-7_009.jpg	Edgar Link	pending
ex10-7_010.jpg	Edgar Link	pending
ex10-7_011.jpg	Edgar Link	pending
ex10-7_012.jpg	Edgar Link	pending
ex10-8.htm	Edgar Link	pending
ex10-8_001.jpg	Edgar Link	pending
ex10-8_002.jpg	Edgar Link	pending
ex10-8_003.jpg	Edgar Link	pending
ex10-8_004.jpg	Edgar Link	pending
ex10-8_005.jpg	Edgar Link	pending
ex10-9.htm	Edgar Link	pending
ex10-91_001.jpg	Edgar Link	pending
ex10-91_002.jpg	Edgar Link	pending
ex10-9_001.jpg	Edgar Link	pending
ex10-9_002.jpg	Edgar Link	pending
ex10-9_003.jpg	Edgar Link	pending
ex10-9_004.jpg	Edgar Link	pending
ex10-9_005.jpg	Edgar Link	pending
ex10-9_006.jpg	Edgar Link	pending
ex10-9_007.jpg	Edgar Link	pending
ex10-9_008.jpg	Edgar Link	pending
ex10-9_009.jpg	Edgar Link	pending
ex10-9_1.htm	Edgar Link	pending
ex14-1.htm	Edgar Link	pending
ex14-1_001.jpg	Edgar Link	pending
ex14-1_002.jpg	Edgar Link	pending
ex14-1_003.jpg	Edgar Link	pending
ex14-1_004.jpg	Edgar Link	pending
ex14-1_005.jpg	Edgar Link	pending
ex14-2.htm	Edgar Link	pending
ex14-2_001.jpg	Edgar Link	pending
ex14-2_002.jpg	Edgar Link	pending
ex14-2_003.jpg	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-1_001.jpg	Edgar Link	pending
ex3-1_002.jpg	Edgar Link	pending
ex3-1_003.jpg	Edgar Link	pending
ex3-1_004.jpg	Edgar Link	pending
ex3-1_005.jpg	Edgar Link	pending
ex3-1_006.jpg	Edgar Link	pending
ex3-1_007.jpg	Edgar Link	pending
ex3-1_008.jpg	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex3-2_001.jpg	Edgar Link	pending
ex3-2_002.jpg	Edgar Link	pending
ex3-2_003.jpg	Edgar Link	pending
ex3-2_004.jpg	Edgar Link	pending
ex3-2_005.jpg	Edgar Link	pending
ex3-2_006.jpg	Edgar Link	pending
ex3-2_007.jpg	Edgar Link	pending
ex3-2_008.jpg	Edgar Link	pending
ex3-2_009.jpg	Edgar Link	pending
ex3-2_010.jpg	Edgar Link	pending
ex3-2_011.jpg	Edgar Link	pending
ex3-2_012.jpg	Edgar Link	pending
ex3-2_013.jpg	Edgar Link	pending
ex3-2_014.jpg	Edgar Link	pending
ex3-2_015.jpg	Edgar Link	pending
ex3-2_016.jpg	Edgar Link	pending
ex3-2_017.jpg	Edgar Link	pending
ex3-3.htm	Edgar Link	pending
ex3-3_001.jpg	Edgar Link	pending
ex3-3_002.jpg	Edgar Link	pending
ex3-3_003.jpg	Edgar Link	pending
ex3-3_004.jpg	Edgar Link	pending
ex3-4.htm	Edgar Link	pending
ex3-4_001.jpg	Edgar Link	pending
ex3-4_002.jpg	Edgar Link	pending
ex3-4_003.jpg	Edgar Link	pending
ex3-4_004.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
aphp-20240331_cal.xml	Edgar Link	unprocessable
aphp-20240331_def.xml	Edgar Link	unprocessable
aphp-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aphp-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APHP
American Picture House Corp Stock $aphp

2024 Q2 Form 10-Q Financial Statement

#000149315224019186 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APHP American Picture House Corp Stock $aphp

2024 Q2 Form 10-Q Financial Statement

#000149315224019186 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APHP
American Picture House Corp Stock $aphp